Finding new treatments for inflammation that causes early birth
Discovery of Novel Therapeutics for Inflammation Induced Preterm Birth
This study is looking at how inflammation and infections can cause babies to be born too early, and it's for anyone interested in finding new ways to prevent early labor by developing better treatments.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University Medical Center NIH-funded |
| Lab location | 1 site (Nashville, United States) |
| Project ID | NIH-11119417 on NIH RePORTER |
What this research studies
This research focuses on understanding how inflammation and infection can lead to preterm birth, which occurs before 37 weeks of pregnancy. The project involves developing new therapeutic approaches to manage these conditions using advanced techniques in gestational tissue modeling. The research will be conducted at Vanderbilt University Medical Center, where the team will utilize a combination of hands-on training, coursework, and mentorship to explore innovative drug discovery methods. The ultimate goal is to create effective interventions that can help prevent early labor caused by infections.
Who could benefit from this research
Good fit: Ideal candidates for this research are pregnant individuals at risk of preterm birth due to inflammation or infection.
Not a fit: Patients who are not pregnant or those whose preterm birth is not related to inflammation or infection may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that significantly reduce the incidence of preterm birth and improve outcomes for infants.
How similar studies have performed: Previous research has shown promise in developing therapies for preterm birth, but this approach is innovative and aims to address specific inflammatory triggers.
Where this research is happening
Nashville, United States
- Vanderbilt University Medical Center — Nashville, United States (Active)
Researchers
- Principal investigator: Siricilla, Shajila — Vanderbilt University Medical Center
- Study coordinator: Siricilla, Shajila
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.